Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)

Thats simply not true. To argue to an absurd reduction, if that were true the NHS would preference amputation and wooden limbs over all other treatments for infected limbs. They still preference paths short of amputation.

It's a race to a medium. the problem is the medium is lower than rich people want, and the masses of poorer people who benefit from being lifted above amputation and a wooden leg don't appear in the cashflow as benefactors.

Getting used to a happy medium being lower than many people are used to, is hard.

The most important part of public healthcare is keeping that base level of treatment so any private medical healthcare needs to be at least this mediocre to be worth it.